- Home
- RLMD vs NNVC Comparison
RLMD vs NNVC Comparison
Compare RLMD & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- NNVC
- Stock Information
- Founded
- RLMD 2004
- NNVC 2005
- Country
- RLMD United States
- NNVC United States
- Employees
- RLMD N/A
- NNVC N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- RLMD Health Care
- NNVC Health Care
- Exchange
- RLMD Nasdaq
- NNVC Nasdaq
- Market Cap
- RLMD 20.3M
- NNVC 22.5M
- IPO Year
- RLMD N/A
- NNVC N/A
- Fundamental
- Price
- RLMD $0.64
- NNVC $1.68
- Analyst Decision
- RLMD Buy
- NNVC
- Analyst Count
- RLMD 3
- NNVC 0
- Target Price
- RLMD $5.00
- NNVC N/A
- AVG Volume (30 Days)
- RLMD 211.8K
- NNVC 310.1K
- Earning Date
- RLMD 08-11-2025
- NNVC 05-15-2025
- Dividend Yield
- RLMD N/A
- NNVC N/A
- EPS Growth
- RLMD N/A
- NNVC N/A
- EPS
- RLMD N/A
- NNVC N/A
- Revenue
- RLMD N/A
- NNVC N/A
- Revenue This Year
- RLMD N/A
- NNVC N/A
- Revenue Next Year
- RLMD N/A
- NNVC N/A
- P/E Ratio
- RLMD N/A
- NNVC N/A
- Revenue Growth
- RLMD N/A
- NNVC N/A
- 52 Week Low
- RLMD $0.24
- NNVC $0.94
- 52 Week High
- RLMD $4.02
- NNVC $2.34
- Technical
- Relative Strength Index (RSI)
- RLMD 50.91
- NNVC 59.77
- Support Level
- RLMD $0.60
- NNVC $1.54
- Resistance Level
- RLMD $0.74
- NNVC $1.79
- Average True Range (ATR)
- RLMD 0.06
- NNVC 0.10
- MACD
- RLMD 0.00
- NNVC 0.01
- Stochastic Oscillator
- RLMD 44.19
- NNVC 73.81
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.